Compare WAY & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAY | MIR |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.7B |
| IPO Year | 2024 | N/A |
| Metric | WAY | MIR |
|---|---|---|
| Price | $34.37 | $25.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $47.86 | $28.57 |
| AVG Volume (30 Days) | 1.6M | ★ 3.6M |
| Earning Date | 10-29-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | 0.10 |
| Revenue | ★ $1,039,842,000.00 | $902,300,000.00 |
| Revenue This Year | $15.31 | $8.15 |
| Revenue Next Year | $16.18 | $19.02 |
| P/E Ratio | ★ $55.23 | $246.49 |
| Revenue Growth | ★ 14.76 | 7.82 |
| 52 Week Low | $29.78 | $12.00 |
| 52 Week High | $48.11 | $30.28 |
| Indicator | WAY | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 38.45 | 48.73 |
| Support Level | $34.48 | $24.50 |
| Resistance Level | $35.64 | $25.75 |
| Average True Range (ATR) | 1.22 | 1.18 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 13.84 | 67.19 |
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.